logo-loader
viewBiotechnology Innovation Organization (BIO)

BIO President says House Speaker Pelosi's drug price bill could be a 'disaster' in bio innovation

BIO President Jim Greenwood sat down with Proactive at the 2019 BIO Investor Forum. 

Greenwood talks about how current legislation being introduced by House Speaker Nancy Pelosi to lower drug prices would affect the bio business, as well as the work BIO is doing in this space. 

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: XPhyto sees Germany as key market as they announce deal with...

XPhyto (CSE: XPHY- OTC: XPHYF) CEO Hugh Rogers and Bunker, Managing Director Wolfgang Probst joined Steve Darling from Proactive Vancouver to share news the company has signed a deal with German Brewer Oettinger development, production, and distribution of cannabis-infused beverages and...

2 days, 7 hours ago

2 min read